Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Benjamin Cole

Pediatrics Westerville, OH Medical Doctor

NPI 1215399670 CMS profile 2314549

625 Africa Rd Ste 300, Westerville, OH 43082

Open in the dashboard

General payments

$3,018

176 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Benjamin Cole of Westerville, OH is reported in the CMS Open Payments database as having received $3,018 across 176 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $540 30
2024 General $648 33
2023 General $577 31
2022 General $575 33
2021 General $422 31
2020 General $156 11
2019 General $100 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Benjamin Cole
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Benjamin Cole were reported at $540. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Benjamin Cole Pediatrics median Middle half National median
2019 $100 $86 $31–$183 $163
2020 $156 $49 $22–$110 $114
2021 $422 $68 $27–$158 $132
2022 $575 $77 $30–$173 $149
2023 $577 $88 $33–$190 $160
2024 $648 $94 $34–$206 $164
2025 $540 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Corium, Inc. $460 22 payments
  2. Supernus Pharmaceuticals, Inc. $356 19 payments
  3. Neos Therapeutics, LP $336 26 payments
  4. GlaxoSmithKline, LLC. $243 14 payments
  5. Ironshore Pharmaceuticals Inc. $212 12 payments
  6. Merck Sharp & Dohme Corporation $199 13 payments
  7. Sanofi Pasteur Inc. $180 8 payments
  8. Pfizer Inc. $145 9 payments
  9. Cranial Technologies, Inc $110 7 payments
  10. Sanofi-Aventis U.S. LLC $103 6 payments
  11. Other $673 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,018 176 payments
Products named General payments · program years 2019–2025
  1. Azstarys $460 22 payments
  2. BEXSERO $243 14 payments
  3. QELBREE Psychology $211 11 payments
  4. Adzenys XR-ODT $200 14 payments
  5. GARDASIL 9 $188 12 payments
  6. VAXELIS Vaccines $180 8 payments
  7. COTEMPLA XR-ODT $153 13 payments
  8. MENQUADFI $151 7 payments
  9. VAXELIS Vaccine $147 9 payments
  10. Qelbree Viloxazine Hydrochloride $146 8 payments
  11. Other $2,288 137 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

176 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record